Sherif Ashraf Fahmy

53PUBLICATIONS
57CO-AUTHORS
Molecular targetsBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Sep 25, 2026
Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy.

|Jul 08, 2026
Structure-Based Design, Synthesis, and Biological Evaluation of Oxadiazole-Morpholine Hybrids as Potent PARP-1 Inhibitors Inducing Apoptosis in Breast Cancer Cells.

|Jun 15, 2026
Triazole-Sulfonamide Hybrids as Carbonic Anhydrase Inhibitors: Emerging Chemistry and Bioactivity Insights From 2020 to 2025.

|May 12, 2026
Dual-Function Lipid-Based Nanovector Strategy for Glioblastoma Immunotherapy: STING Activation and M1 Microglia Polarization.

|May 04, 2026
Correction: Fahmy et al. PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells. Pharmaceutics 2022, 14, 407.

|May 04, 2026
Correction: Fahmy et al. Palladium Nanoparticles Fabricated by Green Chemistry: Promising Chemotherapeutic, Antioxidant and Antimicrobial Agents. Materials 2020, 13, 3661.

Pageof 9

Frequent Collaborators

13 joint publications

Hassan Mohamed El-Said Azzazy

12 joint publications

Udo Bakowsky

11 joint publications

Mohamed S Nafie

10 joint publications

Nada K Sedky